Industry: Pharmaceuticals, Biotechnology
GeoVax is a Biotechnology company developing human vaccines for diseases caused by HIV-1 (Human Immunodeficiency Virus – AIDS) and other infectious agents. Our goals include: developing AIDS vaccines for global markets, manufacturing and testing these vaccines under GMP/GLP conditions (FDA guidelines), conducting phase I/II and III human trials for vaccine safety and effectiveness and obtaining regulatory approval of these vaccines in the USA and specified international markets. Outstanding preclinical results: GeoVax DNA/MVA vaccine protected 96% of non-human primates for over 3½ yrs. To our knowledge, this level of protection has not been achieved by other candidate vaccines. Successful Phase I Human clinical DNA vaccine trials have demonstrated the safety of our vaccine(details). ( www.geovax.com )
GeoVax Inc.
1256 Briarcliff Road
Atlanta, Georgia 30306
USA
Tel: (404) 727-0971
Fax: (404) 712-9357